Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 8.


Gremese, E., Alivernini, S., Tolusso, B. et al. (2 more authors) (2019) JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. Journal of Leukocyte Biology, 106 (5). pp. 1063-1068. ISSN 0741-5400

Fisher, K.H., Fragiadaki, M., Pugazhendhi, D. et al. (5 more authors) (2018) A genome-wide RNAi screen identifies MASK as a positive regulator of cytokine receptor stability. Journal of Cell Science, 131. jcs209551. ISSN 0021-9533

Fragiadaki, M. and Zeidler, M.P. (2018) Ankyrin repeat and Single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs. Journal of Biological Chemistry . ISSN 0021-9258

Chinnaiya, K., Lawson, M.A., Thomas, S. et al. (8 more authors) (2017) Low-dose methotrexate in myeloproliferative neoplasm models. Haematologica, 102 (6). 165738. ISSN 0390-6078

Fisher, K.H., Stec, W., Brown, S. et al. (1 more author) (2016) Mechanisms of JAK/STAT pathway negative regulation by the short coreceptor Eye Transformer/Latran. Molecular Biology of the Cell, 27 (3). pp. 434-441. ISSN 1059-1524

Thomas, S.J., Snowden, J.A., Zeidler, M.P. et al. (1 more author) (2015) The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. British Journal of Cancer, 113 (3). 365 - 371. ISSN 0007-0920

Thomas, S., Fisher, K.H., Snowden, J.A. et al. (3 more authors) (2015) Methotrexate Is a JAK/STAT Pathway Inhibitor. PLoS ONE, 10 (7). e0130078. ISSN 1932-6203

Fisher, K.H., Wright, V.M., Taylor, A. et al. (2 more authors) (2012) Advances in genome-wide RNAi cellular screens: a case study using the Drosophila JAK/STAT pathway. BMC Genomics, 13. 506. ISSN 1471-2164

This list was generated on Sun Jan 12 08:50:02 2020 GMT.